Why the study?
Does low-dose aspirin reduce the risk of cardiovascular events and mortality in patients with prior cardiovascular disease or acute myocardial infarction?
Population
Individuals with a history of prior cardiovascular disease and those with suspected evolving myocardial…
Comparison
Low-dose aspirin vs Placebo or control
Design
Review
Authors
Loading...
Reinforces aspirin for secondary prevention and acute MI; leaves open optimal dosing amid modern therapies.
Does low-dose aspirin reduce the risk of cardiovascular events and mortality in patients with prior cardiovascular disease or acute myocardial infarction?
Low-dose aspirin is of proven value in reducing vascular events and mortality in patients who have survived MI, stroke, or unstable angina, as well as those with suspected evolving MI.
C H Hennekens (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: